National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1031318

Case Details

VAERS ID: 1031318 (history)  
Form: Version 2.0  
Age: 0.75  
Sex: Male  
Location: Foreign  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Exposure via breast milk, Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neonatal exposures via breast milk (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Vaccination (had his 6 month vaccinations)
Diagnostic Lab Data:
CDC Split Type: IEPFIZER INC2021095061

Write-up: RASH AND HIVES ON ARMS AND OUTER THIGHS; RASH AND HIVES ON ARMS AND OUTER THIGHS; REACTION IN A BABY WHO WAS BEING BREASTFED; This is a spontaneous report from a contactable other healthcare professional, downloaded from the Regulatory Authority, IE-HPRA-2021-063693. This is a report received from the Regulatory Authority. The mother of a 9-month-old male patient received the first dose of bnt162b2 (COMIRNATY, batch/lot no: EM0477), via an unspecified route on 12Jan2021 at single dose for covid-19 immunisation. The patient had no relevant medical history/concurrent conditions. There were no concomitant medications. The patient previously had his 6 month vaccinations, ibuprofen (NUROFEN FOR CHILDREN) and paracetamol. On 12Jan2021, the patient''s mother (39 years old) was vaccinated with her first dose of bnt162b2. The patient was exposed via the transmammary route. On 13Jan2021, at 10 am, the patient experienced rash and hives on his arms and outer thighs. The reaction continued over 24 hours after three separate breastfeeds. The patient''s mother outlined that she intended to wean the infant before the second vaccine. At the time of reporting, the patient had recovered from the events. Serious criteria for the case was reported as medical significant. No follow-up attempts are possible. No further information is expected.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166